Full text is available at the source.
Abstract
Messenger RNA (mRNA) therapeutics have transitioned into a clinically validated therapeutic platform.
- mRNA therapeutics were previously considered experimental but have shown clinical validation.
- The use of mRNA therapeutics was notably accelerated by their application during the COVID-19 pandemic.
- Interest in mRNA therapeutics has expanded to potential applications beyond just infectious diseases.
Simplified